伊克西祖马布作为一个成功治疗儿科泛性性牛皮的治疗方法
Maria Esposito1,2, Paolo Antonetti3,4, Emanuele Vagnozzi3,4
1Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L' Aquila, Via Vetoio, Coppito 2, L' Aquila, 67100, Italy. maria.esposito3@univaq.it.
Italian journal of pediatrics
|February 11, 2025
概括
泛性皮囊性牛皮 (GPP) 是一种罕见的,严重的皮肤疾病. 一种IL-17A抗剂Ixekizumab有效地治疗了儿科GPP病例,在52周内显示持续缓解和安全性.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 儿科风湿病学 儿科风湿病学
- 自燃性炎症疾病 自燃性炎症疾病
背景情况:
- 泛性性牛皮 (GPP) 是一种罕见的,严重的自身炎症性疾病.
- 通过,发烧和全身炎症的特征,GPP可以危及生命,特别是在儿童中.
- 病原发生涉及IL-36,IL-1,TNF-alpha和IL-17A,其中IL-17A对中性粒细胞招募至关重要.
研究的目的:
- 报告一个儿科泛性皮质银病 (GPP) 病例的成功治疗.
- 评估Ixekizumab在儿科GPP患者中的疗效和安全性.
主要方法:
- 一名患有GPP的7岁女孩,耐循环氨酸,接受了Ixekizumab (IL-17A对抗剂) 的治疗.
- 最初的治疗包括Ixekizumab (80毫克) 和短时间的普得尼松疗程,然后每4周服用Ixekizumab (40毫克).
- 在实现缓解后,剂量间隔延长到6周.
主要成果:
- 患者在第8周内实现了皮肤表现的完全缓解和血液细胞的正常化.
- 持续缓解维持了52周的ixekizumab治疗,没有安全问题.
- 治疗证明了短期和长期的疗效.
结论:
- 伊克西祖马布 (Ixekizumab) 是对儿科通用状牛皮 (GPP) 的安全有效的治疗选择.
- 这一案例凸显了IL-17A对抗在儿童GPP管理中的潜力.
- 需要进行更大规模的研究,以在更广泛的儿科患者群体中证实这些发现.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K